Literature DB >> 16212896

Gene therapy of cancer: induction of anti-tumor immunity.

Cheng Qian1, Jesus Prieto.   

Abstract

Many malignancies lack satisfactory treatment and new therapeutic options are urgently needed. Gene therapy is a new modality to treat both inherited and acquired diseases based on the transfer of genetic material to the tissues. Different gene therapy strategies against cancers have been developed. A considerable number of preclinical studies indicate that a great variety of cancers are amenable to gene therapy. Among these strategies, induction of anti-tumor immunity is the most promising approach. Gene therapy with cytokines has reached unprecedented success in preclinical models of cancer. Synergistic rather than additive effects have been demonstrated by combination of gene transfer of cytokines/chemokines, costimulatory molecules or adoptive cell therapy. Recent progress in vector technology and in imaging techniques allowing in vivo assessment of gene expression will facilitate the development of clinical applications of gene therapy, a procedure which may have a notorious impact in the management of cancers lacking effective treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16212896

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  2 in total

1.  Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.

Authors:  Ana P Castano; Pawel Mroz; Mei X Wu; Michael R Hamblin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

Review 2.  Antibody drug conjugate: the "biological missile" for targeted cancer therapy.

Authors:  Zhiwen Fu; Shijun Li; Sifei Han; Chen Shi; Yu Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.